Lilly Trademark Details
Word Mark | Lilly |
---|---|
Status | Dead 602 — Abandoned-Failure to Respond or Late Response |
Current Owner
Eli Lilly and Company of Indianapolis, IN
View all trademarks for Eli Lilly and CompanySerial Number | 86612327 |
---|---|
Status Date | Thursday, June 30, 2016 |
Filing Date | Thursday, June 30, 2016 |
Attorney | Bruce W. Longbottom |
Correspondent
BRUCE W. LONGBOTTOM
Eli Lilly and Company
Lilly Corporate Center
Indianapolis, IN 46285-0001
Eli Lilly and Company
Lilly Corporate Center
Indianapolis, IN 46285-0001
Case File Statements
Indication of Colors | The color(s) LIGHT YELLOW, DARK YELLOW is/are claimed as a feature of the mark. |
---|---|
Description of Mark | The Mark Consists of a Configuration of a Three Dimensional Tablet in the Shape of an Irregular Oval; with the Word "Lilly" in Script Debossed on the Face of the Tablet; in the Colors Light Yellow, with Dark Yellow on the Sides of the Tablet and Framing the Word "Lilly". |
Goods & Services | Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, Parkinson's disease, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antidepressants; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases |
Classifications
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Friday, May 8, 2015 |
Primary Code | 005 |
Trademark Timeline
-
Apr 28 2015Trademark application filed with USPTO
-
May 01 2015New Application Entered In Tram
-
May 08 2015New Application Office Supplied Data Entered In Tram
-
May 09 2015Notice of Design Search Code E-Mailed
-
May 28 2015Assigned To Examiner
-
Jun 04 2015Notification of Non-Final Action E-Mailed
-
Jun 04 2015Non-Final Action E-Mailed
-
Jun 04 2015Non-Final Action Written
-
Nov 12 2015Correspondence Received In Law Office
-
Nov 12 2015Teas Response To Office Action Received
-
Nov 13 2015Teas/email Correspondence Entered
-
Dec 03 2015Notification of Final Refusal Emailed
-
Dec 03 2015Final Refusal E-Mailed
-
Dec 03 2015Final Refusal Written
-
Jun 30 2016Abandonment - Failure To Respond Or Late Response
-
Jul 01 2016Abandonment Notice Mailed - Failure To Respond